Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma

Cancer Genetics and Cytogenetics

Volumn 98, Issue 1, 1997, Pages 43-49

  Ohtani Fujita, Naoko ^a   Dryja, Thaddeus P ^g   Rapaport, Joyce M ^g   Fujita, Tsuyoshi ^a   Matsumura, Satoshi ^a   Ozasa, Kotaro ^a   Watanabe, Yoshiyuki ^a   Hayashi, Kyohei ^a   Maeda, Koshi ^a   Kinoshita, Shigeru ^a   Matsumura, Takafumi ^a   Ohnishi, Yoshitaka ^c   Hotta, Yoshihiro ^d   Takahashi, Rei ^b   Kato, Mitsuo V ^b   Ishizaki, Kanji ^b   Sasaki, Masao S ^b   Horsthemke, Bernhard ^f   Minoda, Kensei ^e   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BASE PAIRING; BINDING SITE; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; RETINOBLASTOMA;

BLOTTING, SOUTHERN; DNA METHYLATION; GENES, RETINOBLASTOMA; HUMANS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA;

EID: 0030848575     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00395-0     Document Type: Article

References (25)

1. Goodrich DW, Lee W-H (1993): Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1155:43-61.
2. Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley EG, Dryja TP (1989): Oncogenic point mutations in the human Retinoblastoma gene: Their application to genetic counseling. N Engl J Med 321:1689-1695.
3. Hogg A, Bia B, Onadim Z, Cowell JK (1993): Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci USA 90:7351-7355.
4. Schimizu T, Toguchida J, Kato MV, Kaneko A, Ishizaki K, Sasaki MS (1994): Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Am J Hum Genet 54:793-800.
5. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee W-H (1990): Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87:7762-7766.
6. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991): Ocogenic germline mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 353:83-86.
7. Cedar H (1988): DNA methylation and gene activity. Cell 53:3-4.
8. Greger V, Passarge E, Höpping W, Messmer E, Horsthemke B (1989): Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83:155-158.
9. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP (1991): Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880-888.
10. Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B (1994): Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94: 491-496.
11. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T (1993): CpG methylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene 8:1063-1067.
12. Dryja TP, Mukai S, Petersen R, Rapaport JM, Walton D, Yandell DW (1989): Parental origin of mutations of the retinoblastoma gene. Nature 339:556-558.
13. Toguchida J, Ishizaki K, Sasaki MS, Nakamura Y, Ikenaga M, Kato M, Sugimoto M, Kotoura Y, Tamamuro T (1989): Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338:156-158.
14. Zhu X, Dunn JM, Phillips RA, Goddard AD, Paton KE, Becker A, Gallie BL (1989): Preferential germline mutation of the paternal allele in retinoblastoma. Nature 340:312-313.
15. Mantel N (1963): Chi-square tests with one-degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690-700.
16. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP (1993): Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17: 535-543.
17. Zacksenhaus E, Gill RM, Phillips RA, Gallie BL (1993) Molecular cloning and characterization of the mouse RB1 promoter. Oncogene 8:2343-2351.
18. Gill RM, Hamel PA, Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA (1994): Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ 5:467-474.
19. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan D-SR, Gnarra JR, Linehan WM, Baylin SB (1994): Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
20. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-P J, Davidson NE, Sidransky D, Baylin SB (1995): Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530.
21. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995): 5′ CpG island methylation is associated with transcriptional silencing of the tumor-suppressor p16/CDKN2/MST1 in human cancers. Nature Med 1:686-692.
22. Makos-Wales M, Biel MA, El-Deiry W, Nelkin BD, Issa J.-P, Cavanee WK, Kuerbitz SJ, Baylin SB (1995): p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nature Med 1:570-577.
23. Makos M, Nelkin BD, Leman MI, Latif F, Zbar B, Baylin SB (1992): Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89:1929-1933.
24. Wu J, Issa J-P, Herman J, Bassett DE Jr., Nelkin BD, Baylin SB (1993): Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 90:8891-8895.
25. Vogel F (1979): Genetics of retinoblastoma. Hum Genet 52:1-54.